Encourages the use of SMEs. Knowledge from the people who actually use and build the system is prioritized over generic compliance templates. 4. Supplier Involvement
The transition from GAMP 4 to GAMP 5 reflects the evolving needs of the pharmaceutical industry, with a greater emphasis on a systematic, risk-based approach to the validation and compliance of computerized systems. Companies must understand and implement these guidelines to ensure that their automated systems are reliable, secure, and compliant with regulatory requirements, ultimately safeguarding product quality and patient safety. gamp 4 vs gamp 5 difference